Stockscreener 앱 받기
2.07
1.43%
-0.03
시간 외 거래:
2.07
전일 마감가:
$2.10
열려 있는:
$2.1
하루 거래량:
28,000
Relative Volume:
0.02
시가총액:
$3.08M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-2.875
EPS:
-0.72
순현금흐름:
$-7.30M
1주 성능:
-3.27%
1개월 성능:
-17.20%
6개월 성능:
-33.87%
1년 성능:
-72.67%
1일 변동 폭
$2.07
$2.17
1주일 범위
$2.07
$2.2699
52주 변동 폭
$1.835
$8.418
Tharimmune Inc Stock (THAR) Company Profile
명칭
Tharimmune Inc
전화
302-743-2995
주소
1200 ROUTE 22 EAST, BRIDGEWATER
THAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
2.07 | 3.08M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tharimmune Inc 주식(THAR)의 최신 뉴스
tharimmune CEO Randy Milby buys shares worth $9,752 - Investing.com
Tharimmune, Inc. Appoints Sanam Parikh to Its Board of Directors - Marketscreener.com
Tharimmune plans Phase 2 trial for itch treatment TH104 - Investing.com
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update - Eagle-Tribune
Tharimmune Advances TH104 Clinical Program: Phase 2 Trial Set for 2025 After Positive Phase 1 Results - StockTitan
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.55% - MSN
Tharimmune announces $2.02M private placement; shares up - MSN
Tharimmune (NASDAQ:THAR) Coverage Initiated at Rodman & Renshaw - Defense World
Rodman & Renshaw Initiates Coverage of Tharimmune (THAR) with Buy Recommendation - MSN
Tharimmune secures $2.02 million in private funding By Investing.com - Investing.com Nigeria
THARTharimmune, Inc. Latest Stock News & Market Updates - StockTitan
Tharimmune secures $2.02 million in private funding - Investing.com
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs - Eagle-Tribune
Tharimmune Secures $2M Strategic Investment to Advance Chronic Pruritus Treatment Pipeline - StockTitan
Rodman & Renshaw sets price target on Tharimmune shares, rating Buy - Investing.com
Tumor necrosis factor (TNF)-alpha Inhibitor Market Will Witness Growth with Emerging Therapies by 2034 | - EIN News
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025 - AccessWire
Tharimmune appoints new board member, cancels Intract merger By Investing.com - Investing.com South Africa
Tharimmune appoints new board member, cancels Intract merger - Investing.com
Tharimmune Abandons Acquisition of Intract Pharma - MarketWatch
Penn State wins trademark case over retailer's use of vintage logos, images - Corsicana Daily Sun
Oil company Phillips 66 faces federal charges related to alleged Clean Water Act violations - Corsicana Daily Sun
Valsoft Corporation Enters the Book Industry Software Space with the Acquisition of Edelweiss - Corsicana Daily Sun
Travelers Capital and TCC Financial Bolster Investor Relations Service, Compliance, and Growth with the Appointment of Mark Breakspear - Corsicana Daily Sun
Oleria Named a Winner in Fast Company's 2024 Next Big Things in Tech Awards - Corsicana Daily Sun
Congratulations to Tenorshare for Winning French Design Award - Corsicana Daily Sun
LQR House Inc. Board of Directors Approves Purchase of Up to $1M Bitcoin as Treasury Reserve Asset and Retention of Up to $10M Crypto Payments on CWSpirits.com - Corsicana Daily Sun
Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate - Corsicana Daily Sun
Sterling Metals Completes 3D IP Survey at Copper Road, Discovers New Outcrop Areas and Extends Mineralized Footprint - Corsicana Daily Sun
BofA Strengthens Support for Arizona Entrepreneurs through State’s Largest Supplier Diversity Program Impact AZ - Corsicana Daily Sun
Diversified Announces Upcoming Investor Engagement - Corsicana Daily Sun
What's Going On With Tharimmune Shares Monday? - Benzinga
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease - Brazosport Facts
MSP Recovery announces 1-for-25 reverse stock split to regain Nasdaq compliance - MSN
Pre-market Movers: ELAB, PHGE, CLDI, BJDX... - RTTNews
Tharimmune COO Appajosyula Sireesh acquires $10,096 in stock - Investing.com India
Tharimmune COO Appajosyula Sireesh acquires $10,096 in stock By Investing.com - Investing.com Canada
Tharimmune set to receive European patent for cancer therapy tech By Investing.com - Investing.com Canada
What's Going On With Tharimmune Shares Wednesday? - MSN
Tharimmune set to receive European patent for cancer therapy tech - Investing.com
Tharimmune Secures Key European Patent for Revolutionary Nanoparticle Drug Delivery System | THAR Stock News - StockTitan
GC Football: Player of the Week - Corsicana Daily Sun
Hoverfly Technologies Promotes Steve Topping to Chief Operating Officer - Corsicana Daily Sun
Tharimmune Announces Upcoming Conference Presentations - StockTitan
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.22% - MSN
Dow Surges Over 150 Points; Alphabet Posts Upbeat Results - MSN
United States shares lower at close of trade; Dow Jones Industrial Average down 0.22% - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.22% - MSN
S&P 500 Edges Lower; US Crude Oil Inventories Fall - MSN
New Jersey-Based Biotech Company Finds Massive Mid-Week Success Following "Positive Feedback" - MSN
Tharimmune Inc (THAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tharimmune Inc 주식 (THAR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Appajosyula Sireesh | Chief Operating Officer |
Nov 13 '24 |
Buy |
2.02 |
5,000 |
10,096 |
10,758 |
| MILBY RANDY | CEO |
Oct 08 '24 |
Buy |
2.09 |
2,500 |
5,221 |
12,934 |
| Appajosyula Sireesh | Chief Operating Officer |
Oct 08 '24 |
Buy |
1.93 |
5,000 |
9,650 |
16,364 |
2.88%
2.65%
자본화:
|
볼륨(24시간):